Solid Biosciences Inc. (SLDB)
$5.82-13.26%Close
SELLCRISIS · day 15
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $573M
- Beta
- 2.47
- P/E (TTM)
- -3.05
- Short % float
- 16.27%
- Days to cover
- 7.7
- SI change
- -25.6%
- 1W
- -15.90%
- 1M
- -33.41%
- vs SPY 1W
- -15.76%
- vs SPY 1M
- -35.92%
Industry peers
FMP comparable companies · ranked by market cap
- PTCTSELLPTC Therapeutics, Inc.$5.3BCRISISQ 18$62.92-4.77%
- EWTXSELLEdgewise Therapeutics, Inc.$4.1BCRISISQ 15$38.45-5.64%
- DYNSELLDyne Therapeutics, Inc.$3.0BCRISISQ 3$15.96-4.14%
- SRPTSELLSarepta Therapeutics, Inc.$1.8BCRISISQ 13$17.44-5.33%
- MGTXSELLMeiraGTx Holdings plc$961MCRISISQ 6$10.38-4.24%
- FDMTSELL4D Molecular Therapeutics, Inc.$680MRECOVERYQ 3$13.00-4.92%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 13
- VALUE
- 8
- GROWTH
- 47
- GARP
- 5
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-43.4%
REV YoY-
ROE-72.3%
EPS YoY-
ROA-49.2%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM-3.05
P/E FWD-
SECTOR PE20.34
INDUSTRY PE13.84
P/B1.71
P/FCF-
EV/EBITDA-2.11
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E5.39
ALTMAN Z-
CURR RATIO13.82
ND/EBITDA-
BETA2.47
Company news
FAQ
- What is LOPJLB’s current signal on SLDB?
- LOPJLB’s latest quantitative signal on Solid Biosciences Inc. (SLDB) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is SLDB in?
- Solid Biosciences Inc. (SLDB) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Solid Biosciences Inc. (SLDB) do?
- Solid Biosciences Inc. is an American biotechnology firm dedicated to creating therapeutic solutions for Duchenne Muscular Dystrophy (DMD). Its most advanced experimental drug, SGT-001, is a gene transfer treatment currently in Phase I/II clinical trials, designed to encourage the production of functional dystrophin protein in patients' muscles. The company is also progressing with SGT-003, whi…